Prevalence of cancer survivors in the United States
JNCI: Journal of the National Cancer Institute · 01.11.2024 · 116 (11) · 1784-1790
DOI: 10.1093/jnci/djae135 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 13.07.2024. Verfasst von Emily Tonorezos und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 322-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
With aging of the population and improvements in diagnosis, treatment, and supportive care, the number of cancer survivors in the United States has increased; updated prevalence estimates are needed.
Methods
Cancer prevalence on January 1, 2022, was estimated using the Prevalence Incidence Approach Model, utilizing incidence, survival, and mortality. Prevalence by age decade, sex, and time from diagnosis was calculated. The percentage of cancer survivors in the projected US population by age and sex was calculated as the ratio of the sex-specific projected prevalence to the sex-specific projected US population.
Results
There were an estimated 18.1 million US cancer survivors as of January 1, 2022. From 2022 to 2030, the number of US cancer survivors is projected to increase to 21.6 million; by 2040, the number is projected to be 26 million. Long-term survivors are highly prevalent; in 2022, 70% of cancer survivors had lived 5 years or more after diagnosis, and 11% of cancer survivors had lived 25 years or more after diagnosis. Among all US females aged 40-54 years, 3.6% were cancer survivors; among females aged 65-74 years, 14.5% were cancer survivors; among females aged 85 years and older, 36.4% were cancer survivors. Among all US males aged 40-54 years, 2.1% were cancer survivors; among males aged 65-74 years, 16% were cancer survivors; and among those aged 85 years and older, 48.3% were cancer survivors.
Conclusions
Cancer survivors are growing in number. In the United States, most cancer survivors are long-term and very long-term survivors, representing a substantial proportion of the US population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
- Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.
ORCID-Profile: Emily Tonorezos, Lisa Gallicchio, Paige Green, Michelle Doose, Janet S de Moor
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Tonorezos, E., Devasia, T., Mariotto, A. B., Mollica, M. A., Gallicchio, L., Green, P., Doose, M., Brick, R., Streck, B., Reed, C., & de Moor, J. S. (2024). Prevalence of cancer survivors in the United States. JNCI: Journal of the National Cancer Institute, 116(11), 1784-1790. https://doi.org/10.1093/jnci/djae135
Vancouver
Tonorezos E, Devasia T, Mariotto AB, Mollica MA, Gallicchio L, Green P, et al. Prevalence of cancer survivors in the United States. JNCI: Journal of the National Cancer Institute. 2024;116(11):1784-1790. doi:10.1093/jnci/djae135
BibTeX
@article{Tonorezos2024,
author = {Tonorezos, Emily and Devasia, Theresa and Mariotto, Angela B and Mollica, Michelle A and Gallicchio, Lisa and Green, Paige and Doose, Michelle and Brick, Rachelle and Streck, Brennan and Reed, Crystal and de Moor, Janet S},
title = {Prevalence of cancer survivors in the United States},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
volume = {116},
number = {11},
pages = {1784--1790},
doi = {10.1093/jnci/djae135}
}
EUVIMED